Patents by Inventor Sabi Airouche

Sabi Airouche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposes
    Patent number: 9868770
    Abstract: The present invention concerns a method for producing a recombinant Dermatophagoides pteronyssinus 2 protein (rDer p 2), comprising the steps of cultivating a Pichia pastoris yeast strain previously transformed with a rDer p 2 coding sequence, and isolating the rDer p 2 protein from said Pichia pastoris yeast strain. The invention also relates to compositions and kits comprising the rDer p 2 protein for therapeutic or diagnostic use.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: January 16, 2018
    Assignee: STALLERGENES
    Inventors: Véronique Bordas, Laetitia Bussieres, Sabi Airouche, Sophie Tourdot, Emmanuel Nony, Philippe Moingeon, Julien Bouley
  • C1q as a therapeutic agent of allergy and/or asthma
    Publication number: 20160367631
    Abstract: The present invention concerns C1q for use for treating allergy and/or asthma. The invention also relates to a pharmaceutical composition comprising C1q and at least one allergen and to products comprising C1q and at least one allergen as a combined preparation for use for treating allergy and/or asthma.
    Type: Application
    Filed: July 2, 2014
    Publication date: December 22, 2016
    Applicant: STALLERGENES
    Inventors: Laurnt MASCARELL, Philippe MOINGEON, Sabi AIROUCHE, VERONIQUE BODO
  • Recombinant Der P 2 Expressed in Pichia Pastoris as a "Natural-Like" Allergen for Immunotherapy and Diagnostic Purposes
    Publication number: 20110293665
    Abstract: The present invention concerns a method for producing a recombinant Dermatophagoides pteronyssinus 2 protein (rDer p 2), comprising the steps of cultivating a Pichia pastoris yeast strain previously transformed with a rDer p 2 coding sequence, and isolating the rDer p 2 protein from said Pichia pastoris yeast strain. The invention also relates to compositions and kits comprising the rDer p 2 protein for therapeutic or diagnostic use.
    Type: Application
    Filed: May 17, 2011
    Publication date: December 1, 2011
    Inventors: Véronique BORDAS, Laetitia Bussieres, Sabi Airouche, Sophie Tourdot, Emmanuel Nony, Philippe Moingeon, Julien Bouley